Kyriazis John, Katsipi Irene, Stylianou Kostas, Jenakis Nikolaos, Karida Anthoula, Daphnis Eugene
Department of Nephrology, General Hospital of Chios, Chios, Greece.
Nephron Clin Pract. 2007;106(1):c34-42. doi: 10.1159/000101482. Epub 2007 Apr 2.
BACKGROUND/AIMS: We investigated the way dialysate calcium (dCa) level can influence arterial stiffness (AS), measured by stiffness index (SI), a surrogate of pulse wave velocity, and reflection index (RI), a measure of the amount of pulse wave reflection, derived by digital volume pulse (DVP).
Fourteen hemodialysis (HD) patients underwent two consecutive midweek 4-hour HD treatments in randomized order with a low dCa concentration of 1.25 mmol/l (LdCa) and a high dCa concentration of 1.75 mmol/l (HdCa), respectively. Before HD and at 1-hour intervals during the subsequent 4-hour HD sessions, SI and RI measurements were obtained from DVP contour analysis. Blood pressure (BP) and heart rate (HR) were measured after each measurement of AS. Ionized serum calcium (iCa) was measured before HD and at 120 and 240 min into the HD session.
iCa increased and decreased by 15.3 and 5.4% in the HdCa and LdCa groups, respectively, at the end of HD. SI and RI increased by 5.7 and 6% in the HdCa group, respectively, whereas they remained unchanged in the LdCa group. The treatment effect and the time x treatment effect were significant for both indices (ANOVA). BP and HR changes did not differ between treatments.
Contrary to LdCa, HdCa treatment induced a BP-independent, significant increase in measured AS parameters. In the long run, HD with LdCa, by reducing the incidence of HD-induced hypercalcemia, may have a beneficial role in minimizing the cardiovascular risk related to the intermittent, intradialytic increase in AS, inherent in the chronic use of HdCa.
背景/目的:我们研究了透析液钙(dCa)水平对动脉僵硬度(AS)的影响方式,动脉僵硬度通过僵硬度指数(SI)来衡量,SI是脉搏波速度的替代指标,以及反射指数(RI),它是通过数字容积脉搏(DVP)得出的脉搏波反射量的指标。
14名血液透析(HD)患者以随机顺序分别接受两次连续的、在周中进行的4小时HD治疗,低dCa浓度为1.25 mmol/l(LdCa)和高dCa浓度为1.75 mmol/l(HdCa)。在HD治疗前以及随后4小时HD疗程中每隔1小时,通过DVP轮廓分析获得SI和RI测量值。每次测量AS后测量血压(BP)和心率(HR)。在HD治疗前以及HD疗程的120分钟和240分钟时测量血清离子钙(iCa)。
HD结束时,HdCa组和LdCa组的iCa分别升高和降低了15.3%和5.4%。HdCa组的SI和RI分别增加了5.7%和6%,而LdCa组则保持不变。两种指标的治疗效果以及时间×治疗效果均具有统计学意义(方差分析)。不同治疗之间BP和HR的变化没有差异。
与LdCa相反,HdCa治疗导致测量的AS参数出现与BP无关的显著增加。从长远来看,LdCa透析通过降低HD诱导的高钙血症的发生率,可能在最小化与长期使用HdCa所固有的间歇性、透析内AS增加相关的心血管风险方面发挥有益作用。